Introduction: Rare cardiomyopathy left ventricle non-compaction (LVNC) or excess trabeculation is an unclassified heart disease related to the cessation of the normal process of myocardial development during the first trimester of pregnancy. Familial forms account for approximate...
Open access
Research Article10.9734/ca/2024/v13i3420
The aim of this case report is to draw attention at the potential severity of presentation of these associated pathologies. Prevention through early screening of colorectal cancer in patients with coronary artery disease and vice versa is the guarantee of a better management of t...
Open access
Research Article10.9734/ca/2023/v12i3335
Background: Ischemic stroke following thrombolysis for ST-segment elevation myocardial infarction(STEMI) is a rare and perplexing complication. We present an intriguing case of ischemic stroke following fibrinolytic therapy with tenecteplase for a STEMI. This is an extremely rare...
Open access
Research Article10.9734/ca/2022/v11i4303
Carbon monoxide (CO) intoxication is the most frequent etiology of toxicological morbidity and mortality in the world. If the neurological manifestations are in the foreground, then cardiovascular signs of myocardial damage by necrosis are possible, which can result in angina, an...
Open access
Research Article10.9734/ca/2023/v12i4370
AA amyloidosis is a classic and serious complication of many chronic inflammatory processes, whether of infectious, autoimmune, or neoplastic origin. It is frequently complicated by kidney damage, often in the form of a nephrotic syndrome. Giant cell arteritis is a common inflamm...
Open access
Research Article10.9734/ca/2023/v12i4353
Hypertrophic cardiomyopathy (HCM) is the most common non-ischemic cardiomyopathy with a prevalence of 1:500 in the general population, based on the recognition of the phenotype. HCM is defined by the presence of increased left ventricular (LV) wall thickness that is not solely ex...
Open access
Research Article10.9734/ca/2023/v12i4342
LVNC (left ventricular non-compaction) is a rare congenital cardiomyopathy with a reported incidence of 0.05% in adults. It can occur in isolation or affect both ventricles. It’s characterized by prominent LV trabeculae and deep intertrabecular recesses which are filled with bloo...
Open access
Research Article10.9734/ca/2023/v12i3319
BE. Ovaga, IS Alfakihi, H Charif, B. Mohammed SIDI, P.M Mulendele, M. Njie, M. Charfo Bacharou, J Moyambi, M. HABOUB, L. Azzouzi, A Drighril & R. HABBAL·Cardiology and Angiology: An International Journal·2024
Background: Stress cardiomyopathy or Tako-Tsubo syndrome is a heart disease which is most likely linked to an excessive discharge of catecholamines triggered by physical or emotional stress responsible for myocardial toxicity. Tako-tsubo constitutes the main differential diagnosi...
Open access
Research Article10.9734/ca/2024/v13i3419
Takayasu's disease is the first cause of inflammatory aortitis in young subjects. The disease preferentially affects the women. Takayasu's disease could be a mode of non-specific reaction of the aorta to various infectious or dysimmune etiological factors. Aortic insufficiency i...
Open access
Research Article10.9734/ca/2023/v12i4341
Drugs used to treat cardiovascular disease as well as those used in the treatment of multiple other conditions can occasionally produce exaggerated prolongation of the QT interval on the surface electrocardiogram and the morphologically distinctive polymorphic ventricular tachyca...
Open access
Research Article10.9734/ca/2023/v12i3327
P. M. Mulendele, M. Njie, M. B. Charfo, G. M. Lukifimpa, M. S. Boutar, B. E. Ovaga, M. HABOUB, S. AROUS, M. G. Benouna, A. DRIGHIL, L. Azzouzi & R. HABBAL·Cardiology and Angiology: An International Journal·2023
The emergence of immunotherapy and the gradual expansion of its indications in oncology will require particular vigilance to detect and quickly take care of the potential cardiac toxicities. They have improved prognosis and survival, including patients with kidney, lung or skin c...
Open access
Research Article10.9734/ca/2023/v12i4360